SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023)

被引:2
|
作者
Perez-Fidalgo, Jose Alejandro [1 ]
Galvez-Montosa, Fernando [2 ]
Guerra, Eva Maria [3 ]
Madariaga, Ainhoa [4 ]
Manzano, Aranzazu [5 ]
Martin-Lorente, Cristina [6 ]
Rubio-Perez, Maria Jesus [7 ]
Alarcon, Jesus [8 ]
Barretina-Ginesta, Maria Pilar [9 ]
Gaba, Lydia [10 ]
机构
[1] Univ Valencia, Hosp Clin Univ, Biomed Res Inst INCL, Valencia, Spain
[2] Hosp Univ Jaen, Jaen, Spain
[3] Hosp Univ Ramon y Cajal, Madrid, Spain
[4] 12 Octubre Univ Hosp, Dept Med Oncol, Madrid, Spain
[5] Hosp Clin San Carlos, Madrid, Spain
[6] Hosp Santa Creu & Sant Pau, Radiol, Barcelona, Spain
[7] Univ Cordoba UCO, Hosp Univ Reina Sofia, Cordoba, Spain
[8] Hosp Univ Son Espases, Mallorca, Spain
[9] Univ Girona, Inst Invest Biomed Girona IDIBGI, Med Sci Dept, Inst Catala Oncol,Med Oncol Dept,Precis Oncol Grp, Girona, Spain
[10] Univ Barcelona, Hosp Clin, Translat Genom & Targeted Therapies Solid Tumors, Med Oncol Dept,IDIBAPS,Dept Med, Barcelona, Spain
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年 / 26卷 / 11期
关键词
Ovarian cancer; Guideline; Diagnosis; Treatment; PEGYLATED LIPOSOMAL DOXORUBICIN; OPEN-LABEL; MAINTENANCE THERAPY; DOUBLE-BLIND; SECONDARY CYTOREDUCTION; PLUS BEVACIZUMAB; RECURRENT; CHEMOTHERAPY; MULTICENTER; OLAPARIB;
D O I
10.1007/s12094-024-03531-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In recent years, the incorporation of new strategies to the therapeutic armamentarium has completely changed the outcomes of epithelial ovarian cancer (EOC). The identification of new predictive and prognostic biomarkers has also enabled the selection of those patients more likely to respond to targeted agents. Nevertheless, EOC is still a highly lethal disease and resistance to many of these new agents is common. The objective of this guideline is to summarize the most relevant strategies to manage EOC, to help the clinician throughout the challenging diagnostic and therapeutic processes and to provide evidence-based recommendations.
引用
收藏
页码:2758 / 2770
页数:13
相关论文
共 50 条
  • [1] SEOM-GEICO Clinical Guidelines on cervical cancer (2023)
    Manso, Luis
    Ramchandani-Vaswani, Avinash
    Romero, Ignacio
    Sanchez-Lorenzo, Luisa
    Bermejo-Perez, Maria Jose
    Estevez-Garcia, Purificacion
    Farina-Madrid, Lorena
    Garcia, Yolanda Garcia
    Gil-Martin, Marta
    Quindos, Maria
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (11): : 2771 - 2782
  • [2] SEOM-GEICO clinical guidelines on endometrial cancer (2021)
    Pilar Barretina-Ginesta, Maria
    Quindos, Maria
    Damian Alarcon, Jesus
    Esteban, Carmen
    Gaba, Lydia
    Gomez, Cesar
    Perez Fidalgo, Jose Alejandro
    Romero, Ignacio
    Santaballa, Ana
    Jesus Rubio-Perez, Maria
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (04): : 625 - 634
  • [3] SEOM-GEICO clinical guidelines on endometrial cancer (2021)
    María Pilar Barretina-Ginesta
    María Quindós
    Jesús Damián Alarcón
    Carmen Esteban
    Lydia Gaba
    César Gómez
    José Alejandro Pérez Fidalgo
    Ignacio Romero
    Ana Santaballa
    María Jesús Rubio-Pérez
    Clinical and Translational Oncology, 2022, 24 : 625 - 634
  • [4] SEOM clinical guideline in ovarian cancer (2020)
    A. Redondo
    E. Guerra
    L. Manso
    C. Martin-Lorente
    J. Martinez-Garcia
    J. A. Perez-Fidalgo
    M. Q. Varela
    M. J. Rubio
    M. P. Barretina-Ginesta
    A. Gonzalez-Martin
    Clinical and Translational Oncology, 2021, 23 : 961 - 968
  • [5] SEOM Clinical Guideline in ovarian cancer (2016)
    A. Santaballa
    P. Barretina
    A. Casado
    Y. García
    A. González-Martín
    E. Guerra
    N. Laínez
    J. Martinez
    A. Redondo
    I. Romero
    Clinical and Translational Oncology, 2016, 18 : 1206 - 1212
  • [6] SEOM Clinical Guideline in ovarian cancer (2016)
    Santaballa, A.
    Barretina, P.
    Casado, A.
    Garcia, Y.
    Gonzalez-Martin, A.
    Guerra, E.
    Lainez, N.
    Martinez, J.
    Redondo, A.
    Romero, I.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (12): : 1206 - 1212
  • [7] SEOM clinical guideline in ovarian cancer (2020)
    Redondo, A.
    Guerra, E.
    Manso, L.
    Martin-Lorente, C.
    Martinez-Garcia, J.
    Perez-Fidalgo, J. A.
    Varela, M. Q.
    Rubio, M. J.
    Barretina-Ginesta, M. P.
    Gonzalez-Martin, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (05): : 961 - 968
  • [8] SEOM guideline in ovarian cancer 2014
    A. Gonzalez-Martín
    I. Bover
    J. M. Del Campo
    A. Redondo
    L. Vidal
    Clinical and Translational Oncology, 2014, 16 : 1067 - 1071
  • [9] SEOM guideline in ovarian cancer 2014
    Gonzalez-Martin, A.
    Bover, I.
    Del Campo, J. M.
    Redondo, A.
    Vidal, L.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (12): : 1067 - 1071
  • [10] SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023)
    Alonso-Gordoa, Teresa
    Jimenez-Fonseca, Paula
    Martinez-Trufero, Javier
    Navarro, Miguel
    Porras, Ignacio
    Rubio-Casadevall, Jordi
    Arregui Valles, Marta
    Baste, Neus
    Hernando, Jorge
    Iglesias Docampo, Lara
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (11): : 2902 - 2916